(Q67440465)

English

Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivity

scientific article published on 01 March 1976

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivity (English)

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

1 reference

based on heuristic

inferred from title

author name string

G. Gianutsos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1256252

5 September 2022

H. Lal

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1256252

5 September 2022

language of work or name

0 references

publication date

1 March 1976

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0024320576903295?httpAccept=text/xml

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

https://api.elsevier.com/content/article/PII:0024320576903295?httpAccept=text/plain

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

515-520

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

1

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Adrenergic Effect of Chronic Administration of Neuroleptics

2

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

An experimental model of tardive dyskinesia

3

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis

5

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol

6

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Supersensitivity of caudate neurones after repeated administration of haloperidol

7

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

The pharmacology of tardive dyskinesias

8

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

9

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

12

16

307

author name string

Thornburg

publication date

1974

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Journal of Pharmacology and Experimental Therapeutics

13

193

88

author name string

Von Voightlander

publication date

1975

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Journal of Pharmacology and Experimental Therapeutics

14

128

75

author name string

Boyd

publication date

1960

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Effects of amphetamine on the turnover rate of brain catecholamines and motor activity

15

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs

16

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity

17

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

18

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

19

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

20

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Journal of Pharmacology and Experimental Therapeutics

21

174

428

author name string

Lemberger

publication date

1970

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action

22

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Inhibition of anticholinergic drug-induced locomotor stimulation in mice by alpha-methyltyrosine

24

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior

25

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Interactions between central cholinergic agents and amphetamine in mice

28

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour.

29

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine

31

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Influence of noncholinergic drugs on rat striatal acetylcholine levels

32

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Reduced hypothermic effects of cholinomimetic agents following chronic anticholinesterase treatment

33

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Effects of cholinolytic agents on behavior following development of tolerance to low cholinesterase activity

34

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression

35

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal: evidence for dopaminergic supersensitivity in protracted abstinence

36

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Scientific basis of drug dependence

37

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Psychopharmacological evidence for increase in receptor sensitivity following chronic morphine treatment

38

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Actions of acetylcholine and atropine on cerebral cortical neurons in chronically morphine-treated rats

39

1 reference

10.1016/0024-3205(76)90329-5

https://api.crossref.org/works/10.1016/0024-3205(76)90329-5

11 November 2023

Identifiers

10.1016/0024-3205(76)90329-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1256252%20AND%20SRC:MED&resulttype=core&format=json

13 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67440465&oldid=2112570369"